日期 影响因子
日期:
2020 年 — 2026 年
2020
2021
2022
2023
2024
2025
2026
影响因子:
–

Host and bacterial urine proteomics might predict treatment outcomes for immunotherapy in advanced non-small cell lung cancer patients.

宿主和细菌尿液蛋白质组学可能预测晚期非小细胞肺癌患者免疫疗法的治疗结果

期刊:Frontiers in Immunology
影响因子:5.9
doi:10.3389/fimmu.2025.1543817
Dora David, Revisnyei Peter, Pasic Alija, Galffy Gabriella, Dulka Edit, Mihucz Anna, Roskó Brigitta, Szincsak Sara, Iliuk Anton, Weiss Glen J, Lohinai Zoltan
细胞生物学
肺癌
发表日期：2025
文献求助 收藏

From bench to bedside: an interdisciplinary journey through the gut-lung axis with insights into lung cancer and immunotherapy

从实验室到临床：探索肠-肺轴的跨学科之旅，深入了解肺癌和免疫疗法

期刊:Frontiers in Immunology
影响因子:5.9
doi:10.3389/fimmu.2024.1434804
Dora, David; Szőcs, Emőke; Soós, Ádám; Halasy, Viktória; Somodi, Csenge; Mihucz, Anna; Rostás, Melinda; Mógor, Fruzsina; Lohinai, Zoltan; Nagy, Nándor
肺癌
肿瘤
肿瘤免疫
免疫/内分泌
发表日期：2024
文献求助 收藏

Metabolic pathways from the gut metatranscriptome are associated with COPD and respiratory function in lung cancer patients

肠道宏转录组的代谢通路与肺癌患者的慢性阻塞性肺病和呼吸功能相关

期刊:Frontiers in Cellular and Infection Microbiology
影响因子:4.8
doi:10.3389/fcimb.2024.1381170
Dora, David; Revisnyei, Peter; Mihucz, Anna; Kiraly, Peter; Szklenarik, György; Dulka, Edit; Galffy, Gabriella; Lohinai, Zoltan
肺癌
肿瘤
肿瘤免疫
信号转导
代谢
发表日期：2024
文献求助 收藏